Company | FEROZ | Symbol |
Company Name | Ferozsons Laboratories Ltd. | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 14.34 | Average of past year end EPS's |
Sector Average | Rs 19.89 | Sector average of the above |
Avg EPS FV | Rs 117.12 | Fair Value (DCF) based on average of past year end EPS's |
EPS | Rs 13.54 | Last four quarters EPS |
Sector Average | Rs 27.52 | Sector average of the above |
EPS FV | Rs 110.62 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 108.50 | Last closing stock price |
Updated | September 2013 | Data Month/Year |
Div | Rs 7.00 | Total dividend paid during last four quarters |
Sector Average | Rs 12.89 | Sector average of the above |
Div FV | Rs 57.19 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 4.05 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.53 | Sector average of the above |
Avg Div FV | Rs 33.09 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs 67.06 | Fair value (averaged of other fair values) |
Upside | -38.19% | Upside potential (in percentage) based on the above Average. |
Div Yield | 6.45% | Dividend yield |
Sector Average | 2.84% | Sector average of the above |
Book Value | Rs 83.02 | Book Value |
Sector Average | Rs 190.54 | Sector average of the above |
FV FCF/S | Rs 85.96 | Fair Value based on free cash flow per share |
Outstanding Shares | 30,186,841 | Number of Outstanding Shares |
Current Assets | Rs 1,503.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 491.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 33.52 | Net Current Asset Value / Share |
NNWC/S | Rs 15.96 | Net Net Working Capital / Share |
Total Assets | Rs 2,997.00 | Currency in Millions of Pakistan Rupees |
Quarter | September 2012 | Financial Report Quarter |
CfO | Rs 510.00 | Cash from Operations (Millions of Rs) |
FCF/S | Rs 10.52 | Free Cash Flow per Share |
FCF/S Sector Avg | 10.71 | Sector Average FCF/S |
P/FCF | 10.31 | Price over free cash flow |
P/FCF Sector Avg | -54.99 | Sector Average P/FCF |
P/E | 8.01 | Price over earnings ratio |
P/E Sector Avg | -1.68 | Sector Average P/E |
P/B | 1.31 | Price over book value ratio |
P/B Sector Avg | 3.11 | Sector Average P/B |
PR | 51.70 | Payout Ratio (in %) |
PR Sector Avg | 0.68 | Sector average Payout Ratio (in %) |
D/E Ratio | 19.59 | Debt / Equity ratio (%) |
Sector D/E Ratio | 86.87 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 25/09/2013 | |
Last Trade Price | Rs 108.50 | |
3 Months Avg | Rs 116.55 | |
6 Months Avg | Rs 104.83 | |
9 Months Avg | Rs 95.71 | |
12 Months Avg | Rs 94.06 | |
Score | -8 | cumulative +ve's, -ve's from above all |
Buy Scale | 1 | Range -5 to +5 (based on 5 different complex analysis) |
Wednesday, September 25, 2013
FEROZ - Ferozsons Laboratories Ltd. - Company Analysis - 25-09-2013
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment